| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |